SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-21-000031
Filing Date
2021-06-24
Accepted
2021-06-23 17:45:46
Documents
12
Period of Report
2021-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kron-20210623.htm   iXBRL 8-K 44940
  Complete submission text file 0001741830-21-000031.txt   190385

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20210623.xsd EX-101.SCH 1930
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20210623_lab.xml EX-101.LAB 25998
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20210623_pre.xml EX-101.PRE 13745
5 EXTRACTED XBRL INSTANCE DOCUMENT kron-20210623_htm.xml XML 11653
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 211039645
SIC: 2834 Pharmaceutical Preparations